lung cancer
Conditions
Interventions
control group :Routine admission education, standardized oncology care, and pre-discharge guidance.
intervention group:In addition to routine care, patients received Traditional Chinese Medicine (TCM)-based anti-inflammatory dietary guidance.
Sponsors
Shanxi Province Cancer Hospital, China
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Patients with a pathological diagnosis of lung adenocarcinoma. 2) Patients with Stage IIIB-IV disease according to the 8th edition TNM staging system (based on pathology and imaging). 3) Age = 18 years. 4) Inpatients who are ineligible for surgical resection and are receiving a platinum-based plus pemetrexed chemotherapy regimen (as recommended by the NCCN Clinical Practice Guidelines in Oncology). 5) Patients who are aware of their own condition and cancer diagnosis. 6) Patients expected to complete at least two cycles of chemotherapy. 7) Patients with adequate comprehension and verbal who provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1) Coexistence of conditions that may affect complete blood count parameters, such as relevant blood disorders (e.g., leukemia, congenital neutropenia), bone marrow diseases, immune system-related disorders, or severe infections. 2) Use of medications known to influence blood counts or related parameters prior to treatment (excluding pre-treatment premedication), such as glucocorticoids, immunosuppressants (e.g., Tacrolimus, Cyclosporine), or non-steroidal anti-inflammatory drugs (e.g., Aspirin, Indomethacin). 3) Patients with concurrent severe cardiac, renal, pulmonary, or hepatic dysfunction. 4) A history of severe psychiatric disorders or an inability to comply with the study procedures and follow-up schedule. 5) Patients with diabetes mellitus or those with a known allergy to any component of the investigational diet. 6) Concurrent participation in another clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammatory markers; | — |
Secondary
| Measure | Time frame |
|---|---|
| Chinese Version of the FACT-G (Functional Assessment of Cancer Therapy - General); | — |
Countries
China
Contacts
Public ContactWei Gao
Shanxi Province Cancer Hospital, China
Outcome results
None listed